Prenoxdiazine
Chemical compound
- R05DB18 (WHO)
- 1-[2-[3-(2,2-diphenylethyl)-1,2,4-oxadiazol-5-yl]ethyl]piperidine
- 47543-65-7
Y - HCl: 982-43-4 Y
- 120508
- 107586 Y
- S491HH391H
- HCl: 390WW7V7MZ Y
- DTXSID10197192
- Interactive image
- n1c(onc1CC(c2ccccc2)c3ccccc3)CCN4CCCCC4
InChI
- InChI=1S/C23H27N3O/c1-4-10-19(11-5-1)21(20-12-6-2-7-13-20)18-22-24-23(27-25-22)14-17-26-15-8-3-9-16-26/h1-2,4-7,10-13,21H,3,8-9,14-18H2Y
- Key:PXZDWASDNFWKSD-UHFFFAOYSA-NY
Prenoxdiazine (marketed as Libexin) is a cough suppressant.[1] It acts peripherally by desensitizing the pulmonary stretch receptors. Therefore, there's a reduction of cough impulses originating in the lungs. Prenoxdiazine is indicated in cough of bronchial origin.
References
- ^ Csürös L (1989). "Fifteen years of experience on the use of Libexin tablets". Therapia Hungarica. 37 (1): 50–4. PMID 2667194.
- v
- t
- e
Cough and cold preparations (R05)
- Althea root
- Ammonium Chloride
- Antimony pentasulfide
- Cineole
- Creosote
- Guaiacolsulfonate
- Guaifenesin (+codeine, +hydrocodone, +oxomemazine)
- Hederae helicis folium
- Ipecacuanha (Syrup of ipecac)
- Levoverbenone
- Potassium iodide
- Senega
- Tyloxapol
- Acetylcysteine#
- Ambroxol
- Bromhexine
- Carbocisteine
- Dembrexine hydrochloride
- Domiodol
- Dornase alfa
- Eprazinone
- Erdosteine
- Letosteine
- Mannitol
- Mesna
- Neltenexine
- Sobrerol
- Stepronin
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
 | This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
